[1] HOFFMANN A, LEVCHENKO A, SCOTT ML. The ikappaB-NF-kappaB signaling module:temporal control and selective gene activation [J]. Science 2002, 298(5596).
[2] LOPEZ-FRANCO O, SUZUKI Y, SANJUAN G. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis [J]. American Journal of Pathology 2002, 161(04).
[3] Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. [J]. The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation 2001, 2(2).
[4] JOE SAMBROOK, DAVID RUSSELL, 黄培堂. 分子克隆实验指南 [M]. 北京:科学出版社 2003.
[5] FREDERICK M AUSUBEL, ROGER BRENT, ROBERTE KINGSTON, et al. 颜子颖, 王海林. 精编分子生物学实验指南 [M]. 北京:科学出版社 1998.
[6] SIEBENLIST U, FRANZOSO G, BROWN K. Structure, regulation and function of NF-κB [J]. Annual Review of Cell Biology 1994.
[7] CHEN F E, HUANG D B, CHEN Y Q. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA [J]. Nature 1998, 391(22).
[8] BRENT R, PTASHNE M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor [J]. Cell 1985, 43(03).
[9] REN L, CHANG E, MAKKY K. Glutathione S-transferase pull-down assays using dehydrated immobilized glutathione resin [J]. Analytical Biochemistry 2003, 322(02).
[10] BENARD V, BOKOCH GM. Assay of Cdc42, Rac, and Rho GTPase activation by affinity methods [J]. Methods in Enzymology 2002, 345.
[11] Li Y, Jiang Z, Chen H, Ma WJ. A modified quantitative EMSA and its application in the study of RNA-protein interactions. [J]. Journal of Biochemical and Biophysical Methods 2004, 2(2). |
